Immunology

(The Scientist, Vol:4, #22, pg. 20, November 12, 1990) (Copyright, The Scientist, Inc.) -------- R.C. Desrosiers, M.S. Wyand, T. Kodama, D.J. Ringler, et al., "Vaccine protection against simian immunodeficiency virus infection," Proceedings of the National Academy of Sciences, 86, 6353-57, August 1989. Ronald Desrosiers (New England Regional Primate Research Center, Harvard Medical School, Southborough, Mass.): "A vaccine would likely be of greatest public health benefit in stemming the increa

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

(The Scientist, Vol:4, #22, pg. 20, November 12, 1990) (Copyright, The Scientist, Inc.)

-------- R.C. Desrosiers, M.S. Wyand, T. Kodama, D.J. Ringler, et al., "Vaccine protection against simian immunodeficiency virus infection," Proceedings of the National Academy of Sciences, 86, 6353-57, August 1989.

Ronald Desrosiers (New England Regional Primate Research Center, Harvard Medical School, Southborough, Mass.): "A vaccine would likely be of greatest public health benefit in stemming the increasing spread of AIDS. However, making a vaccine to protect against the AIDS virus, HIV, is probably going to be a very difficult task. The difficulties stem largely from the properties of the virus itself and the nature of the persistent infection. HIV, like other members of the lentiretrovirus subgroup, produces a long-term, persistent infection and chronic disease course in spite of an apparently strong host immune response to the infecting virus. Infected individuals may remain clinically well for years, maintaining high ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies